Managing Diabetic Macular Edema in Clinical Practice
The experts discuss strategies, new-generation anti-vascular endothelial growth factors (VEGFs), and the evidence that supports their use. Credit available for this activity expires: 9/30/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002951?ecd=bdc_podcast_libsyn_mscpedu
--------
34:03
--------
34:03
Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers? Credit available for this activity expires: 9/22/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu
--------
36:32
--------
36:32
Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
Are you up to date on new treatment options for thyroid eye disease? Credit available for this activity expires: 9/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu
--------
29:16
--------
29:16
Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway
Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN). Credit available for this activity expires: 9/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002833?ecd=bdc_podcast_libsyn_mscpedu
--------
36:39
--------
36:39
Targeted Therapies for NSCLC: Where Are We Today?
Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer? Credit available for this activity expires: 9/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu
Italia